Exploration of the Active Component and Mechanisms of Shengyu Decoction Against Myelosuppression Using Network Pharmacology and in vitro Experimental Validation.
Bingjie MaPengyi HouRan LiuAijun CangLimei ZhaoPublished in: Drug design, development and therapy (2024)
Our results provided not only the candidate active component of SYD, but also a new insights into mechanism of SYD in the treatment of CIM.
Keyphrases